Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 19/20 | 0.67 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.67 |
| ▸ | CYP8B1 | Q9UNU6 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | CYP51A1 | Q16850 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.67 |
| ▸ | FYN | P06241 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.67 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.67 |
| ▸ | TACR1 | P25103 | 1/20 | 0.67 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.67 |
| ▸ | CCR4 | P51679 | 1/20 | 0.67 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.67 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.67 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6752594 | 1.00 | ABCG2 (0.80) | ABCG2CYP3A4ABCB11CYP8B1LMNA | |
| SCHEMBL6752603 | 1.00 | ABCG2 (0.80) | ABCG2CYP3A4ABCB11CYP8B1LMNA | |
| SCHEMBL6812825 | 1.00 | ABCG2 (0.80) | ABCG2CYP3A4ABCB11CYP8B1LMNA | |
| SCHEMBL7456690 | 1.00 | ABCG2 (0.80) | ABCG2CYP3A4ABCB11CYP8B1LMNA | |
| SCHEMBL4152523 | 0.95 | ABCG2 (0.71) | ABCG2CYP3A4ABCB11CYP8B1LMNA | |
| SCHEMBL4152531 | 0.95 | ABCG2 (0.71) | ABCG2CYP3A4ABCB11CYP8B1LMNA | |
| SCHEMBL7456729 | 0.94 | ABCG2 (0.70) | ABCG2CYP3A4ABCB11CYP8B1LMNA | |
| SCHEMBL17739438 | 0.94 | CYP3A4 (0.72) | ABCG2CYP3A4ABCB11CYP8B1LMNA | |
| SCHEMBL9664951 | 0.94 | CYP3A4 (0.72) | ABCG2CYP3A4ABCB11CYP8B1LMNA | |
| SCHEMBL22679409 | 0.93 | CYP3A4 (0.77) | ABCG2CYP3A4ABCB11CYP8B1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0958289-B1 | AMINO ACID ESTER CONTAINING AZOLE ANTIFUNGALS | JANSSEN PHARMACEUTICA NV (BE) | 2004-06-30 | — | — | EP | disclosed |
| US-6703506-B2 | DIOXOLANE DERIVATIVES AND INTERMEDIATES | JANSSEN PHARMACEUTICA, N.V. (BE) | 2004-03-09 | — | — | US | disclosed |
| US-20030158210-A1 | Amino acid ester containing azole antifungals | MEERPOEL LIEVEN (BE) | 2003-08-21 | — | — | US | disclosed |
| US-6512116-B2 | No drug resistance; intravenous | JANSSEN PHARMACEUTICA NV (BE) | 2003-01-28 | — | — | US | disclosed |
| US-20010039281-A1 | Amino acid ester containing azole antifungals | MEERPOEL LIEVEN (BE) | 2001-11-08 | — | — | US | disclosed |
| US-6262052-B1 | Amino acid ester containing azole antifungals | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158210-A1 | Amino acid ester containing azole antifungals | DAO, SLC7A1, IL4I1 | ABCG2 529/4885CYP3A4 36/4885ABCB11 113/4885 |
| US-20010039281-A1 | Amino acid ester containing azole antifungals | DAO, SLC7A1, IL4I1 | ABCG2 529/4885CYP3A4 36/4885ABCB11 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.